Blog

Cancer Research Institute’s 2024 Spanish-Language Immunotherapy Patient Summit

Photo taken from Cancer Research Institute/LinkedIn

Jun 11, 2024, 01:42

Cancer Research Institute’s 2024 Spanish-Language Immunotherapy Patient Summit

Quoting Cancer Research Institute (CRI) on LinkedIn:

“Featuring Spanish-speaking patients and medical experts, including Dr. Eduardo M. Sotomayor, Vice President and Executive Director of Tampa General Hospital Cancer Institute, and Dr. Narjust Florez, Associate Director of the Cancer Care Equity Program and thoracic medical oncologist at Dana-Farber Cancer Institute, the Cancer Research Institute’s 2024 Spanish-Language Immunotherapy Patient Summit provides Spanish-speaking cancer patients and caregivers with the latest information on immunotherapy and clinical trials, at no cost! Watch the entire summit, moderated by television host and entrepreneur Ana Patricia Gámez, today, or view its individual sessions on-demand.”

Source: Cancer Research Institute (CRI)/LinkedIn

Ana Patricia Gámez cancer Cancer Care Equity Program Cancer Research Institute clinical trials Dana-Farber Cancer Institute Eduardo M. Sotomayor immunotherapy Narjust Florez OncoDaily Oncology Patient Summit Spanish-Language Sure Tampa General Hospital Cancer Institute

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage